NCT05710198View on ClinicalTrials.gov

Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 11, 2023

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2027

Conditions
Glaucoma, Open-Angle
Interventions
DRUG

Citicoline eye drops 2%

Eye drops containing Citicoline 2%

DRUG

Placebo

Eye drops containing placebo matching product

Trial Locations (1)

20142

RECRUITING

Presidio Ospedale San Paolo, Milan

Sponsors
All Listed Sponsors
collaborator

OPIS Spain

INDUSTRY

lead

Omikron Italia S.r.l.

INDUSTRY